Allogeneic Stem Cell Transplantation for Metastatic Renal Cell Cancer (RCC)
<p>A variety of therapeutic options are now available for advanced renal cell cancer, including antiangiogenic and anti-mTOR agents. Allogeneic hematopoietic stem cell transplantation, through its graft-versus-tumor effect, can induce clinical responses and prolonged survival in selected cytok...
Main Author: | Marco Bregni, Fabio Ciceri, Jacopo Peccatori |
---|---|
Format: | Article |
Language: | English |
Published: |
Ivyspring International Publisher
2011-01-01
|
Series: | Journal of Cancer |
Online Access: | http://www.jcancer.org/v02p0347.htm |
Similar Items
-
Innovative Platforms for Haploidentical Stem Cell Transplantation: The Role of Unmanipulated Donor Graft
by: Fabio Ciceri, Marco Bregni, Jacopo Peccatori
Published: (2011-01-01) -
Nonmyeloablative Allogeneic Stem-Cell Transplantation for Metastatic Renal Cell Cancer: A Review and Update
by: P. Erotocritou, et al.
Published: (2006-01-01) -
Breakthrough Invasive Fungal Infections in Allogeneic Hematopoietic Stem Cell Transplantation
by: Carmine Liberatore, et al.
Published: (2021-04-01) -
A Review of Allogeneic Hematopoietic Stem Cell Transplantation in Metastatic Breast Cancer
by: Nuri Karadurmus, et al.
Published: (2018-04-01) -
Editorial: Novel Immunological Biomarkers for Allogeneic HSCT Outcome
by: Raffaella Greco, et al.
Published: (2021-03-01)